Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index rising 1.6% while the SPDR Health Care Select Sector ETF was up 1.5%. The Nasdaq Biotechnology index also was posting a 2.2% gain. In company news, Galapagos (GLPG) was hanging on to a nearly 5% gain late Friday after the European Commission approved an application by the drugmaker and Gildead Sciences (GILD) to sell their Jyseleca rheumatoid arthritis medication for adults who have failed to respond adequately to one or more anti-rheumatic drugs.
Upgrade to Premium and Analyze Stocks Like a Pro
50% Off All Subscriptions